The last that I heard (back on the 9 Nov), the assays were in the lab. You would think that they would have received and interpreted them by now. They can't sit on them under ASX full disclosure rules, although many companies in this space are still to release their assays, so there could be a logjam.
TBH, I am not really thinking along those lines now. I am just waiting patiently to see how this potential T/O play goes down. Only need to be patient and hold tight here for an additional 30-50% (or so I hope).
EAR Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
